Jubilant Cadista Pharmaceuticals, Inc. recalls Irbesartan Tablets, USP, 75 mg, 90- count bottle, Rx only, Manufactured by: Jubilant Generics Ltd. Roorkee- 247661,
Jubilant Cadista Pharmaceuticals recalls 75mg Irbesartan tablets (NDC 59746-447-90) due to failed dissolution specifications. Rx-only bottles from specific lots may not work as intended.
Lower-risk recall
Failed Dissolution Specifications
Contact the company & request your remedy
What happened, in plain English
Jubilant Cadista is recalling 75mg Irbesartan tablets that failed dissolution tests. This means the tablets might not release medication properly when taken, which could affect blood pressure control. Read more at govinfonow.com/recall/34403-jubilant-cadista-recalls-75mg-irbesartan-tablets-failed-dissolution-specs.
Source Summary by GovInfoNow · govinfonow.com/recall/34403-jubilant-cadista-recalls-75mg-irbesartan-tablets-failed-dissolution-specs · Updated September 23, 2026 · FDA enforcement record: FDA #D-1294-2022
Cite this page
“Jubilant Cadista recalls 75mg Irbesartan tablets: Failed dissolution specs.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/34403-jubilant-cadista-recalls-75mg-irbesartan-tablets-failed-dissolution-specs. Based on FDA recall #D-1294-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1294-2022%22&limit=1).
Why it’s dangerous
The tablets failed dissolution specifications, meaning they may not release medication correctly in the body. This could lead to improper blood pressure control if the medication isn't absorbed as intended.
Who’s affected
Prescription users of 75mg Irbesartan tablets from specific lots. People with high blood pressure who take this medication are most at risk.
How to tell if you have this one
Check for NDC 59746-447-90, 90-count bottles, Rx-only, and lots IB120012A, IB120013A, or IB120014A from India. The expiration date is 08/2022.
- Brand
Jubilant Cadista- Category
Drug
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
Nationwide within the United States- NDC
59746-447-30, 59746-447-90, 59746-447-05, 59746-448-30, 59746-448-90, 59746-448-05, 59746-449-30, 59746-449-90, 59746-449-05
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-1293-2022 | Irbesartan Tablets, USP, 150mg, 90- count bottles, Rx only, Manufactured by: Jubilant Generics Ltd. Roorkee- 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-448-90; Lot #: IB220023A, exp. date 08/2022 | 9,600 bottles |
| D-1294-2022 | Irbesartan Tablets, USP, 75 mg, 90- count bottle, Rx only, Manufactured by: Jubilant Generics Ltd. Roorkee- 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-447-90; Lot #: IB120012A, IB120013A, IB120014A Exp. date 08/2022 | 28,560 bottles |
What to do — step by step
Check Product Details
Look for NDC 59746-447-90, 90-count bottles, and specific lots (IB120012A, IB120013A, IB120014A) with expiration 08/2022.
Questions people ask
Why is this product being recalled?
The tablets failed dissolution specifications, meaning they may not release medication properly when taken.
What should I do if I have this product?
The recall record does not specify a remedy, so check with your doctor or pharmacist for guidance.
Are there any safety risks?
The recall indicates a potential issue with medication effectiveness, but the record does not mention serious injury risks.
Contact Jubilant Cadista
We’ve drafted a message you can send Jubilant Cadista to request your refund or repair — edit it as you like.
Subject: Recall D-1294-2022 — Jubilant Cadista Jubilant Cadista Hello, I own a Jubilant Cadista that is covered by recall D-1294-2022 from Jubilant Cadista. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1294-2022 (July 18, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1294-2022 to see it in context.
- Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.